Skip to main content
Caplight Logo









4Tissue

4Tissue

Private
BelgiumHealthcare & Life Scienceshttps://www.4tissue.com/

Last Round

VC Round

Feb 26, 2025

Total Funding Raised

$2.16M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

4Tissue is a biotechnology company that develops bioresorbable hydrogel systems for soft-tissue regeneration, particularly in breast reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

injectable hydrogelbreast reconstructiontissue regenerationregenerative medicinefat graftinglipofillingtissue engineeringbioresorbable materialtissue scaffoldbiomaterialssoft tissue reconstructionMedTechfat transfermedical deviceminimally invasive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4Tissue Comparables

Compare 4Tissue with similar companies based on industry and business-model similarity.

4Tissue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healshape
83%
BellaSeno
81%
Lattice Medical
81%

4Tissue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 26, 2025
SeedOct 23, 2024

Key People

Founding team and executive leadership

Els Hubloux

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 60% MoM.

  • Feb 20, 2026

    Grew 83% QoQ, from 6 to 11 employees.

4Tissue Filings

Explore SEC and related filing metadata, where available.

4Tissue filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 4Tissue's valuation, stock price, and market status.

Is 4Tissue a public or private company?

4Tissue is a private company.

What is the current stock price of 4Tissue?

4Tissue is a private company with no public stock price. No recent secondary market data is available.

How much is 4Tissue worth (valuation)?

Valuation information for 4Tissue is not publicly available.

Can I buy 4Tissue stock?

4Tissue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 4Tissue's last funding round?

4Tissue's most recent funding round was VC Round on February 26, 2025.

Who are the main investors in 4Tissue?

Investor information for 4Tissue is not publicly disclosed.

Will 4Tissue IPO soon?

No public IPO plans have been announced for 4Tissue.

How can I track 4Tissue secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4Tissue's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range11
Year Founded2023
Last FundingFeb 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?